Isolation of Antithrombin III from Normal and α1-Antitrypsin-Deficient Human Plasma

Anna D. Borsodi; Ralph A. Bradshaw

doi:10.1055/s-0038-1651853

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1977; 38(02): 0475-0485
DOI: 10.1055/s-0038-1651853

Original Article

Schattauer GmbH

Isolation of Antithrombin III from Normal and α₁-Antitrypsin-Deficient Human Plasma

Authors

Anna D. Borsodi^*

¹Department of Biological Chemistry, Washington University School of Medicine, St. Louis, MO 63110, U. S. A.
Ralph A. Bradshaw

¹Department of Biological Chemistry, Washington University School of Medicine, St. Louis, MO 63110, U. S. A.

Abstract

Summary

The plasma of individuals, hetero- or homozygous for α₁-antitrypsin deficiency, contains greatly decreased amounts of antithrombin activity as assayed against factor Xa. However, heparin stimulation of the residual antithrombin activity is observed, which is comparable to that of normal plasma. Antithrombins isolated from both normal and α₁-antitrypsin deficient plasma by a simplified procedure are indistinguishable in both properties and yields. The microheterogeneity observed on isoelectric focusing of both preparations can be eliminated by treatment with neuraminidase. Neither purified human antithrombin nor α₁-antitrypsin, when assayed against bovine trypsin, is stimulated by heparin. These results clearly establish the unique natures of antithrombin and α₁-antitrypsin and show that about 75% of the antithrombin activity measured in normal plasma is due to α₁-antitrypsin. Estimates of anti thrombin III activity in normal plasma by assays dependent on enzymatic activity can probably be obtained only in the presence of heparin.

Volltext

Referenzen

References
1 Abildgaard U. 1967; a Purification of Two Progressive Antithrombins of Human Plasma. Scandinavian Journal of Clinical and Laboratory Investigations 19: 190.
2 Abildgaard U. 1967; b Inhibition of the Thrombin-fibrinogen Reaction by Antithrombin III, Studied by N-terminal Analysis. Scandinavian Journal of Clinical and Laboratory Investigations 20: 207.
3 Abildgaard U. 1968; Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis. Scandinavian Journal of Clinical and Laboratory Investigation 21: 89.
4 Abildgaard U, Egeberg O. 1968; Thrombin Inhibitory Activity of Fractions Obtained by Gel Filtration of Antithrombin III Deficient Plasma. Scandinavian Journal of Haematology 5: 155.
5 Biggs R, Denson K. W. E, Akman N, Borrett R, Hadden M. 1970; Antithrombin III, Antifactor Xa and Heparin. British Journal of Haematology 19: 283.
6 Borsodi A. D, Bradshaw R. A, Rughani I. K, Bruce R. M. 1975. Structural and Functional Relationships of Human Antithrombin III and α₁-Antitrypsin. In: Bradshaw R. A, Wessler S. (eds.) Heparin: Structure, Function and Clinical Implications. Plenum Publishing Co.; N.Y.: 249-253.
7 Borsodi A, Narasimhan T. R. 1977 Microheterogeneity of Human Antithrombin. Biochimica et Biophysica Acta. in press.
8 Crawford I. P. 1973; Purification and Properties of Normal Human α₁-Antitrypsin. Archives of Biochemistry and Biophysics 156: 215.
9 Danishefsky F, Tzeng F, Ahrens M, Klein S. 1976; Synthesis of Heparin-Sepharoses and Their Binding with Thrombin and Antithrombin-Heparin Cofactor. Thrombosis Research 8: 131.
10 Davis B. J. 1964; Disc Electrophoresis – II. Method and Application to Human Serum Proteins. Annals of New York Academy of Sciences 121: 404.
11 Desnuelle P, Neurath H, Ottensen M. (eds.) 1969. Structure-Function Relationships of Proteolytic Enzymes. Proceedings of the International Symposium Copenhagen. Academic Press; N. Y.:
12 Duda E. 1973; A New, Sensitive Method for the Determination of Streptomycin. Analytical Biochemistry 51: 651.
13 Egeberg O. 1965; a Inherited Antithrombin Deficiency Causing Thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516.
14 Egeberg O. 1965; b On the Natural Blood Coagulation Inhibitor System. Investigations of Inhibitor Factors Based on Antithrombin Deficient Blood. Thrombosis et Diathesis Haermorrhagica 14: 473.
15 Eriksson S. 1965; Studies on α₁-Antitrypsin Deficiency. Acta Medica Scandinavica 177 Suppl. 432: 5.
16 Frénoy J.-P, Bourrillon R. 1974; Studies on the Structure of Human α₁-Macroglobulin. IV. Analysis of the Microheterogeneity by Isoelectric Focussing. Biochimica et Biophysica Acta 371: 168.
17 Gans H, Tan B. H. 1967; α₁-Anti trypsin, An Inhibitor for Thrombin and Plasmin. Clinica Chimica Acta 17: 111.
18 Kueppers F, Bearn A. G. 1966; A Possible Experimental Approach to the Association of Hereditary α₁-Antitrypsin Deficiency and Pulmonary Emphysema. Proceedings of the Society for Experimental Biology and Medicine 121: 1207.
19 Kurachi K, Schmer G, HermOdson M. A, Teller D, Davie E. W. 1976; Characterization of Human, Bovine, and Horse Antithrombin III. Biochemistry 15: 368.
20 Laemmli U. K. 1970; Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 227: 680.
21 Lanchantin G. F, Plesset M. L, Friedmann J. A, Hart D. W. 1966; Dissociation of Esterolytic and Clotting Activities of Thrombin by Trypsin-binding Macroglobulin. Proceedings of the Society for Experimental Biology and Medicine 121: 444.
22 Laurell C.-B, Eriksson S. 1963; The Electrophoretic α₁-Globulin Pattern of Serum in α₁-Antitrypsin Deficiency. Scandinavian Journal of Clinical and Laboratory Investigation 15: 132.
23 Laurell C.-B, Eriksson S. 1965; The Serum α₁-Antitrypsin in Families with Hypo-α₁-Antitrypsinemia. Clínica Chimica Acta 11: 395.
24 Monkhouse F. C. 1970; Preparation and Assay of Plasma Antithrombin. Methods in Enzymology XIX: 915.
25 Porter P, Porter M. C, Shanberge J. N. 1967; Heparin Cofactor and Plasma Antithrombin in Relation to the Mechanism of Inactivation of Thrombin by Heparin. Clinica Chimica Acta 77: 189.
26 Rimon A, Shamash Y, Shapiro B. 1966; The Plasmin Inhibitor of Human Plasma. IV. Its Action on Plasmin, Trypsin, Chymotrypsin and Thrombin. Journal of Biological Chemistry 241: 5102.
27 Rosenberg R. D, Damus P. S. 1973; The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor. Journal of Biological Chemistry 248: 6490.
28 Schultze H. E, Heide K, Haupt H. 1962; Alpha1-antitrypsin and Human Serum. Klinische Wochenschrift 40: 427.
29 Seegers W. H, Marciniak E. 1962; Inhibition of Autoprothrombin C Activity with Plasma. Nature 193: 1188.
30 Szezeklik A, Teresiak T, KoDaczkowska B. 1971; Niedobor Alfa1-antytrypsyny I Antytrombiny III W Przypadku Rozedmy Pluc. Polskie Archiwum Medycyny Wewnetrznejwi 47: 407.
31 Tan B. H, Gans H. 1969; Alpha1-Antitrypsin. III. Inhibition of Trypsin, Thrombin, Plasmin and Leucoproteinases. Pharmaceutisch Weekblad 104: 717.
32 Wessler S. 1975. Clinical Implications of Heparin. In: Bradshaw R. A, Wessler S. (Eds.) Heparin: Structure, Function, and Clinical Implications. Plenum Publishing Co.; N. Y.: 309-322.
33 Yin E. T, Wessler S, Stoll P. J. 1971; a Rabbit Plasma Inhibitor of The Activated Species of Blood Coagulation Factor X. Purification and Some Properties. Journal of Biological Chemistry 246: 3694.
34 Yin E. T, Wessler S, Stoll P. J. 1971; b Identity of Plasma-activated Factor X Inhibitor with Antithrombin III and Heparin Cofactor. Journal of Biological Chemistry 246: 3712.
35 Yin E. T, Wessler S, Butler J. V. 1973; Plasma Heparin: A Unique, Practical, Submicrogram-sensitive Assay. Journal of Clinical and Laboratory Investigation 81: 298.
36 Zacharius R. M, Zell T. E, Morrison J. H, Woodlock J. J. 1969; Glycoprotein Staining Following Electrophoresis on Acrylamide Gels. Analytical Biochemistry 30: 148.